The University of Southampton
University of Southampton Institutional Repository

Tissue engineering techniques in cardiac repair and disease modelling

Tissue engineering techniques in cardiac repair and disease modelling
Tissue engineering techniques in cardiac repair and disease modelling
Cell therapy has been proposed to treat patients with end-stage heart failure. However, it has been suggested that the significant mechanical forces in an often ischaemic, inflamed, biochemically hostile environment may cause poor cell survival and retention. It is hypothesised that tissue engineering techniques could be used to modify the environment to improve the efficacy of cell therapy. Similarly, it has been suggested that tissue engineering technology could be used to mature the phenotype of immature cardiomyocytes in vitro, making them more useful disease models. In this review we will briefly discuss key tissue engineering techniques and principles that can be used to facilitate cell therapy, and modify the phenotype of immature cardiomyocytes and stem cells.
2048 - 2056
Rao, C.
20f2d12e-20a6-4c86-9174-f1e7a7441ad3
Barratt, H.
c89243e8-ea9c-43fc-a626-798484770a40
Prodromakis, T.
d58c9c10-9d25-4d22-b155-06c8437acfbf
Terracciano, C.M.
79bb2862-f4c4-42b1-929c-3043b5bc8794
Rao, C.
20f2d12e-20a6-4c86-9174-f1e7a7441ad3
Barratt, H.
c89243e8-ea9c-43fc-a626-798484770a40
Prodromakis, T.
d58c9c10-9d25-4d22-b155-06c8437acfbf
Terracciano, C.M.
79bb2862-f4c4-42b1-929c-3043b5bc8794

Rao, C., Barratt, H., Prodromakis, T. and Terracciano, C.M. (2013) Tissue engineering techniques in cardiac repair and disease modelling. Current Pharmaceutical Design, 20 (12), 2048 - 2056. (doi:10.2174/13816128113199990442). (PMID:23844730)

Record type: Article

Abstract

Cell therapy has been proposed to treat patients with end-stage heart failure. However, it has been suggested that the significant mechanical forces in an often ischaemic, inflamed, biochemically hostile environment may cause poor cell survival and retention. It is hypothesised that tissue engineering techniques could be used to modify the environment to improve the efficacy of cell therapy. Similarly, it has been suggested that tissue engineering technology could be used to mature the phenotype of immature cardiomyocytes in vitro, making them more useful disease models. In this review we will briefly discuss key tissue engineering techniques and principles that can be used to facilitate cell therapy, and modify the phenotype of immature cardiomyocytes and stem cells.

Text
23844730 - Other
Restricted to Repository staff only
Request a copy

More information

Accepted/In Press date: 2013
e-pub ahead of print date: 18 June 2013
Published date: 18 June 2013
Organisations: Nanoelectronics and Nanotechnology

Identifiers

Local EPrints ID: 354915
URI: http://eprints.soton.ac.uk/id/eprint/354915
PURE UUID: 5e012b30-f8aa-4f08-bb84-96e623614f7f
ORCID for T. Prodromakis: ORCID iD orcid.org/0000-0002-6267-6909

Catalogue record

Date deposited: 07 Aug 2013 14:09
Last modified: 14 Mar 2024 14:26

Export record

Altmetrics

Contributors

Author: C. Rao
Author: H. Barratt
Author: T. Prodromakis ORCID iD
Author: C.M. Terracciano

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×